TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer von Yardley, Denise A., Arrowsmith, Edward R., Daniel, Brooke R., Eakle, Janice, Brufsky, Adam, Drosick, David R., Kudrik, Fred, Bosserman, Linda D., Keaton, Mark R., Goble, Sharon A., Bubis, Jeffrey A., Priego, Victor M., Pendergrass, Kelly, Manalo, Yvonne, Bury, Martin, Gravenor, Donald S., Rodriguez, Gladys I., Inhorn, Roger C., Young, Robyn R., Harwin, William N., Silver, Caryn, Hainsworth, John D., Burris, Howard A.

Volltext

Phase II Multicenter Study of Docetaxel and Bevacizumab With or Without Trastuzumab as First-Line Treatment for Patients With Metastatic Breast Cancer von Schwartzberg, Lee S, Badarinath, Suprith, Keaton, Mark R, Childs, Barrett H

Volltext

Anti-HER-2 therapy following severe trastuzumab-induced cardiac toxicity von Sadek, Ibrahim, Keaton, Mark, Maihle, Nita J., Tang, Shou-Ching

Volltext

A Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel With or Without Trastuzumab in Metastatic Breast Cancer von Mirtsching, Barry, Cosgriff, Thomas, Harker, Graydon, Keaton, Mark, Chidiac, Tarek, Min, Myo

Volltext

Sorafenib or Placebo with Either Gemcitabine or Capecitabine in Patients with HER-2―Negative Advanced Breast Cancer That Progressed during or after Bevacizumab von SCHWARTZBERG, Lee S, TAUER, Kurt W, BELL-MCGUINN, Katherine, KIRSHNER, Jeffrey J, EISENBERG, Peter, EMANUELSON, Richard, KEATON, Mark, LEVINE, Ellis, MEDGYESY, Diana C, QAMAR, Rubina, STARR, Alexander, SUNHEE KWON RO, HERMANN, Robert C, LOKKER, Nathalie A, HUDIS, Clifford A, MAKARI-JUDSON, Grace, ISAACS, Claudine, THADDEUS BECK, J, KAKLAMANI, Virginia, STEPANSKI, Edward J, RUGO, Hope S, WEI WANG

Volltext

Designing Railroad Operating Plans: A Dual Adjustment Method for Implementing Lagrangian Relaxation von Keaton, Mark H

Volltext

PI3K mutation and effect of aspirin use in breast cancer von Tang, Shou-Ching, Raval, Priyanka, Sonbol, Mohamad Bassam, Simmons, Josh David, Chintalapally, Rohini, Savage, Natasha, Kolhe, Ravindra B., Kitamura, Eiko, Chang, Chang-Sheng, Keaton, Mark Robert, Maihle, Nita J., Kim, Sangmi

Volltext

A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma von Ko, Andrew H., Youssoufian, Hagop, Gurtler, Jayne, Dicke, Karel, Kayaleh, Omar, Lenz, Heinz-Josef, Keaton, Mark, Katz, Terry, Ballal, Shaila, Rowinsky, Eric K.

Volltext

TITAN: Phase III study of doxorubicin/cyclophosphamide (AC) followed by ixabepilone (Ixa) or paclitaxel (Pac) in early-stage, triple-negative breast cancer (TNBC) von Yardley, Denise A., Bosserman, Linda D., Keaton, Mark Robert, Ackerman, Mary Audrey, Goble, Sharon A., Shipley, Dianna, Salloum, Emile, Harwin, William N., Daniel, Brooke R., Hainsworth, John D., Burris, Howard A.

Volltext

Designing optimal railroad operating plans: Lagrangian relaxation and heuristic approaches von Keaton, Mark H.

Volltext

Highlights of the 2015 San Antonio Breast Cancer Symposium von Keaton, Mark, Tripathy, Debu, O'Shaughnessy, Joyce, Tang, Shou-Ching

Volltext

A phase II trial of pemetrexed and gemcitabine as first line therapy for poor performance status and/or elderly patients with stage IIIB/IV non-small cell lung cancer von Blakely, L. Johnetta, Schwartzberg, Lee, Keaton, Mark, Schnell, Fred, Henry, David, Epperson, Amanda, Walker, Mark S

Volltext

A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer von Brufsky, Adam, Hoelzer, Karen, Beck, Thaddeus, Whorf, Robert, Keaton, Mark, Nadella, Padma, Krill-Jackson, Elisa, Kroener, Joan, Middleman, Edward, Frontiera, Michael, Paul, Devchand, Panella, Timothy, Bromund, Jane, Zhao, Luping, Orlando, Mauro, Tai, Fritz, Marciniak, Martin D, Obasaju, Coleman, Hainsworth, John

Volltext

Are there economies of traffic density in the Less-Than-Truckload motor carrier industry? An operations planning analysis von Keaton, Mark H.

Volltext

A Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel With or Without Trastuzumab in Metastatic Breast Cancer von Mirtsching, Barry, Cosgriff, Thomas, Harker, Graydon, Keaton, Mark, Chidiac, Tarek, Min, Myo

Volltext

Scalable fair reliable multicast using active services von Kasera, S.K., Supratik Bhattacharyya, Keaton, M., Kiwior, D., Zabele, S., Kurose, J., Towsley, D.

Volltext

P2-316: Phase II trial of pemetrexed and gemcitabine as first-line chemotherapy for elderly and/or poor performance status patients with stage iiib/iv non-small cell lung cancer (N... von Schwartzberg, Lee S., Blakely, Johnetta, Keaton, Mark, Schnell, Fred, Henry, David, Tucker, Steven

Volltext

SEARCHLIGHT DISTRIBUTED QOS MANAGEMENT von KEATON, Mark, HELSINGER, Aaron, UPTHEGROVE, Timothy, CARO, Armando

Volltext bestellen

SEARCHLIGHT DISTRIBUTED QOS MANAGEMENT von Keaton, Mark, Helsinger, Aaron Mark, Upthegrove, Timothy, Caro, Jr., Armando L

Volltext bestellen

Using the gamma distribution to model demand when lead time von Keaton, Mark

Volltext